Search alternatives:
therapy resistance » chemotherapy resistance (Expand Search)
decrease therapy » increased therapy (Expand Search), decreases thereby (Expand Search)
increased plant » increased post (Expand Search)
decrease plant » decreases plaque (Expand Search)
Showing 1 - 20 results of 11,516 for search '(( decrease therapy resistance ) OR ( ((decrease plant) OR (increased plant)) resistance ))*', query time: 0.44s Refine Results
  1. 1
    Sensitivity Analysis 1—increased fitness and decreased probability of treatment success given joint resistance, 2018–2025.

    Sensitivity Analysis 1—increased fitness and decreased probability of treatment success given joint resistance, 2018–2025. by Amber Kunkel (3208332)

    Published 2021
    Save to List
    Saved in:
  2. 2
    Sensitivity Analysis 3—the fitness of jointly resistant strains is increased; the probability of DP-MQ successfully treating jointly resistant strains is decreased; and the probability of successful treatment of resistant strains with DP is forced to equal that with ASMQ.

    Sensitivity Analysis 3—the fitness of jointly resistant strains is increased; the probability of DP-MQ successfully treating jointly resistant strains is decreased; and the probabi... by Amber Kunkel (3208332)

    Published 2021
    Save to List
    Saved in:
  3. 3
    Nanomediated Stimulation: An Alternative to Brassinolide Hormone Replacement Therapy for Plant Resistance Activation

    Nanomediated Stimulation: An Alternative to Brassinolide Hormone Replacement Therapy for Plant Resistance Activation by Hui Feng (174331)

    Published 2025
    “…Our results showed the prestimulated leaves of zinc oxide nanoparticles (ZnONPs) exhibit accelerated antiviral capability, and the plant resistance activation was increased with a decrease in the ZnONP size. …”
    Save to List
    Saved in:
  4. 4
    Nanomediated Stimulation: An Alternative to Brassinolide Hormone Replacement Therapy for Plant Resistance Activation

    Nanomediated Stimulation: An Alternative to Brassinolide Hormone Replacement Therapy for Plant Resistance Activation by Hui Feng (174331)

    Published 2025
    “…Our results showed the prestimulated leaves of zinc oxide nanoparticles (ZnONPs) exhibit accelerated antiviral capability, and the plant resistance activation was increased with a decrease in the ZnONP size. …”
    Save to List
    Saved in:
  5. 5
    Nanomediated Stimulation: An Alternative to Brassinolide Hormone Replacement Therapy for Plant Resistance Activation

    Nanomediated Stimulation: An Alternative to Brassinolide Hormone Replacement Therapy for Plant Resistance Activation by Hui Feng (174331)

    Published 2025
    “…Our results showed the prestimulated leaves of zinc oxide nanoparticles (ZnONPs) exhibit accelerated antiviral capability, and the plant resistance activation was increased with a decrease in the ZnONP size. …”
    Save to List
    Saved in:
  6. 6
    Nanomediated Stimulation: An Alternative to Brassinolide Hormone Replacement Therapy for Plant Resistance Activation

    Nanomediated Stimulation: An Alternative to Brassinolide Hormone Replacement Therapy for Plant Resistance Activation by Hui Feng (174331)

    Published 2025
    “…Our results showed the prestimulated leaves of zinc oxide nanoparticles (ZnONPs) exhibit accelerated antiviral capability, and the plant resistance activation was increased with a decrease in the ZnONP size. …”
    Save to List
    Saved in:
  7. 7
    Nanomediated Stimulation: An Alternative to Brassinolide Hormone Replacement Therapy for Plant Resistance Activation

    Nanomediated Stimulation: An Alternative to Brassinolide Hormone Replacement Therapy for Plant Resistance Activation by Hui Feng (174331)

    Published 2025
    “…Our results showed the prestimulated leaves of zinc oxide nanoparticles (ZnONPs) exhibit accelerated antiviral capability, and the plant resistance activation was increased with a decrease in the ZnONP size. …”
    Save to List
    Saved in:
  8. 8
    Changes in data-based resistance and data-based aggressiveness during therapy.

    Changes in data-based resistance and data-based aggressiveness during therapy. by Kanyarat Jitmana (18693060)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 9
    ALDH2 inhibitors decrease stroma-induced ALDH activity in AML cells and sensitize them to chemotherapy.

    ALDH2 inhibitors decrease stroma-induced ALDH activity in AML cells and sensitize them to chemotherapy. by Bin Yuan (19897)

    Published 2020
    Save to List
    Saved in:
  10. 10
    Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance

    Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance by Rachel A. O’Keefe (8269389)

    Published 2020
    “…Currently, there are no biomarkers used in the clinic to predict which HNSCC tumors will respond to cetuximab, and even in tumors that regress with treatment, acquired resistance occurs in the majority of cases. Though a number of mechanisms of acquired resistance to cetuximab have been identified in preclinical studies, no therapies targeting these resistance pathways have yet been effectively translated into the clinic. …”
    Save to List
    Saved in:
  11. 11
    Details of planting material.

    Details of planting material. by Harpreet Singh (677440)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 12
    Metabolites increased and decreased by drought stress.

    Metabolites increased and decreased by drought stress. by Yuanjie Weng (19193658)

    Published 2024
    Save to List
    Saved in:
  13. 13
    p38 MAPK inhibitor decreases ALDH2 expression in AML cells in the presence of TGF-β1 or stromal cells.

    p38 MAPK inhibitor decreases ALDH2 expression in AML cells in the presence of TGF-β1 or stromal cells. by Bin Yuan (19897)

    Published 2020
    Save to List
    Saved in:
  14. 14
    In the absence of <i>eIF4E1</i>, global translation activity decreases while virus accumulation increases.

    In the absence of <i>eIF4E1</i>, global translation activity decreases while virus accumulation increases. by Delyan Zafirov (17420106)

    Published 2023
    Save to List
    Saved in:
  15. 15
    Decreased nicotine mediated by increased auxin accounts for the susceptibility of SL-RNAi plants to <i>T</i>. <i>mucorea</i> attack.

    Decreased nicotine mediated by increased auxin accounts for the susceptibility of SL-RNAi plants to <i>T</i>. <i>mucorea</i> attack. by Suhua Li (1314660)

    Published 2020
    Save to List
    Saved in:
  16. 16
    Silicon in plant disease control

    Silicon in plant disease control by Edson Ampélio Pozza (6826385)

    Published 2021
    “…<div><p>All essential nutrients can affect the incidence and severity of plant diseases. Although silicon (Si) is not considered as an essential nutrient for plants, it stands out for its potential to decrease disease intensity in many crops. …”
    Save to List
    Saved in:
  17. 17
    Proposed model of apoptotic-like programmed cell death (AL-PCD) in plants.

    Proposed model of apoptotic-like programmed cell death (AL-PCD) in plants. by Bikram Poudel (15989201)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance

    Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  19. 19
    Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance

    Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  20. 20
    Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance

    Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

    Published 2023
    Subjects:
    Save to List
    Saved in:

Search Tools: